Is Senolytic Therapy in Cardiovascular Diseases Ready for Translation to Clinics?
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Senolytic drugs show promise for cardiovascular diseases by clearing aging cells, but recent studies reveal potential detrimental effects. Further research is crucial to understand these controversies for safe clinical translation.
Area Of Science
- Cardiovascular Medicine
- Gerontology
- Cellular Biology
Background
- Aging is a major risk factor for cardiovascular diseases (CVDs).
- Senescent cells contribute to aging and CVD pathogenesis, even in younger individuals.
- Eliminating senescent cells shows potential for reversing aging and treating age-related diseases.
Purpose Of The Study
- To analyze beneficial and detrimental effects of senolytic therapies in cardiovascular aging and diseases.
- To discuss future research directions for translating senolytic therapy into clinical practice.
Main Methods
- Review of existing literature on senolytic approaches in cardiovascular research.
- Analysis of studies reporting both positive and negative outcomes of senolytic interventions.
- Identification of controversies and knowledge gaps in senolytic therapy for CVDs.
Main Results
- Senolytic therapy demonstrates beneficial effects in aging cardiomyopathies, ischemia/reperfusion injury, and atherosclerotic vascular disease.
- Controversial findings include worsened cardiac dysfunction, plaque instability, and increased mortality in animal models.
- The efficacy and safety of senolytic drugs in cardiovascular conditions require further investigation.
Conclusions
- Senolytic drugs represent a potential next-generation therapy for cardiovascular disorders.
- Contradictory results challenge the clinical translation of senolytic approaches.
- Understanding the dual effects of senolytics is essential for developing safe and effective treatments for cardiovascular aging and diseases.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...